92 related articles for article (PubMed ID: 32239101)
21. Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules.
Kwon GY; Yoo BC; Koh KC; Cho JW; Park WS; Park CK
J Korean Med Sci; 2005 Apr; 20(2):242-7. PubMed ID: 15831995
[TBL] [Abstract][Full Text] [Related]
22. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas.
Kanai Y; Ushijima S; Hui AM; Ochiai A; Tsuda H; Sakamoto M; Hirohashi S
Int J Cancer; 1997 May; 71(3):355-9. PubMed ID: 9139867
[TBL] [Abstract][Full Text] [Related]
23. Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC).
Hashiguchi M; Ueno S; Sakoda M; Iino S; Hiwatashi K; Minami K; Ando K; Mataki Y; Maemura K; Shinchi H; Ishigami S; Natsugoe S
BMC Cancer; 2013 Dec; 13():572. PubMed ID: 24304617
[TBL] [Abstract][Full Text] [Related]
24. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
[TBL] [Abstract][Full Text] [Related]
25. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma.
Cho SB; Lee KH; Lee JH; Park SY; Lee WS; Park CH; Kim HS; Choi SK; Rew JS
Pathol Int; 2008 Oct; 58(10):635-42. PubMed ID: 18801083
[TBL] [Abstract][Full Text] [Related]
26. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN
Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
28. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
29. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.
Ha SY; Kim JH; Yang JW; Bae H; Cho HY; Park CK
Pathol Res Pract; 2016 Jul; 212(7):616-21. PubMed ID: 27083241
[TBL] [Abstract][Full Text] [Related]
30. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
31. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
Xu J; Wang J; Hu Y; Cheng L; Yu H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
[TBL] [Abstract][Full Text] [Related]
32. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
33. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma - clinicopathological characteristics, survival, and expression of various histologic molecular markers.
Nikolova D; Ivanova V; Dimitrova M; Jovanovik R; Kunovska S; Orovcanec N; Petrushevska G; Janevska V
Pol J Pathol; 2019; 70(4):269-276. PubMed ID: 32146796
[TBL] [Abstract][Full Text] [Related]
35. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
Fransvea E; Angelotti U; Antonaci S; Giannelli G
Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline.
Zhu C; Feng X; Ye G; Huang T
Medicine (Baltimore); 2017 Apr; 96(16):e6650. PubMed ID: 28422868
[TBL] [Abstract][Full Text] [Related]
37. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
Liu Y; Jiang P; Wang G; Liu X; Luo S
Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
[TBL] [Abstract][Full Text] [Related]
39. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
40. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]